Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 May 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

SOFA and MELD predicts intensive care mortality in cirrhosis

Mortality in intensive care with cirrhosis is high, and the latest Alimentary Pharmacology & Therapeutics shows that the Model for End-stage Liver Disease predicts the risk better than Acute Physiology and Chronic Health Evaluation II or Child-Pugh scores.

News image

Prognostic scores in an intensive care unit evaluate outcomes, but derive from cohorts containing few cirrhotic patients.

Professor Burroughs and colleagues from England evaluated 6-week mortality in cirrhotic patients admitted to an intensive care unit.

The investigative team compared general and liver-specific prognostic scores.

A total of 312 consecutive cirrhotic patients, of which 65% were alcoholic with a mean age of 50 years.

The investigators used multivariable logistic regression to evaluate admission factors associated with survival.

Child-Pugh, Model for End-stage Liver Disease (MELD), Acute Physiology and Chronic Health Evaluation (APACHE) II scores were assessed.

In addition, the team evaluated the Sequential Organ Failure Assessment (SOFA) scores.

The various scores were compared by receiver operating characteristic curves.

Cirrhotics in intensive care with 3 or more failing organ systems have 90% mortality
Alimentary Pharmacology & Therapeutics

The investigators found that the major indication for admission was respiratory failure, in 36%.

Median Child-Pugh, and Acute Physiology and Chronic Health Evaluation II scores were 11 and 18.

The team noted that Model for End-stage Liver Disease and Sequential Organ Failure Assessment scores were 24 and 11, respectively.

The investigators observed that 65% of patients died.

Survival improved over time.

Multivariate model factors included more organs failing, higher FiO2, lactate, urea and bilirubin.

The team found that these factors resulted in good discrimination.

This was similar to Sequential Organ Failure Assessment and Model for End-stage Liver Disease.

In addition, the team noted that it was superior to Acute Physiology and Chronic Health Evaluation II and Child-Pugh scores.

Professor Burroughs' team concluded, “Cirrhotics admitted to intensive care with 3 or more failing organ systems have 90% mortality.”

“The Royal Free model discriminated well and contained key variables of organ function.”

“Sequential Organ Failure Assessment and Model for End-stage Liver Disease were better predictors than Acute Physiology and Chronic Health Evaluation II or Child-Pugh scores.”

Aliment Pharmacol Ther 2006: 23(7): 883
24 March 2006

Go to top of page Email this page Email this page to a colleague

 25 May 2016 
Preventing NSAID-associated GI toxicity
 25 May 2016 
Recurrence of Barrett’s after successful endoscopic therapy
 25 May 2016 
PPIs and NSAID-induced small bowel injury
 24 May 2016 
Fecal inflammatory markers in Crohn's
 24 May 2016 
Depression and IBD recurrence
 24 May 2016 
New therapies for NASH
 23 May 2016 
Risk factors for peptic ulcer bleeding outcomes
 23 May 2016 
Liver transplantation for hepatocellular carcinoma
 23 May 2016 
Cancer after colectomy in IBD
 20 May 2016 
Biomarker for colorectal cancer diagnosis
 20 May 2016 
Prognostic score for hepatic venous outflow obstruction
 20 May 2016 
Treatment for uncomplicated acute diverticulitis
 19 May 2016 
Probiotics and H. pylori eradication
 19 May 2016 
Impaired skeletal health in atrophic gastritis
 19 May 2016 
Predicting outcome in ulcerative colitis
 18 May 2016 
Erectile dysfunction in IBD
 18 May 2016 
Acute GERD and esophageal histologic changes
 18 May 2016 
Surgical fundoplication for GERD 
 17 May 2016 
Mucosal dysbiosis in Crohn's disease
 17 May 2016 
Vitamin D level and clinical status in IBD 
 17 May 2016 
Inpatient costs for IBD and acute pancreatitis
 16 May 2016 
Outcomes of postcolonoscopy colorectal cancers
 16 May 2016 
C. difficile in ulcerative colitis patients
 16 May 2016 
Therapy for Crohn's in a Medicaid population
 13 May 2016 
Parkinson's disease and IBD
 13 May 2016 
Non-traditional heart disease risk factors in NAFLD
 13 May 2016 
Inactivated oral cholera vaccine
 12 May 2016 
Gestational diabetes mellitus and NAFLD
 12 May 2016 
Impact of Crohn's in the USA
 12 May 2016 
Ozanimod induction and ulcerative colitis
 11 May 2016 
Anti-TNF discontinuation in IBD
 11 May 2016 
Age and disease presentation with Crohn's disease
 11 May 2016 
Prognosis after colorectal cancer resection
 10 May 2016 
Gluten-free diet in patients with IBS-diarrhea
 10 May 2016 
Noninvasive test for IBD
 10 May 2016 
Digital health for gastroenterology
 09 May 2016 
Diarrheal infections in adults
 09 May 2016 
Quality improvement initiative and readmission for cirrhosis
 09 May 2016 
Coffee or tea and the risk of Barrett's
 06 May 2016 
Recurrent pancreatitis after acute pancreatitis
 06 May 2016 
Risk factors in peptic ulcer bleeding
 06 May 2016 
Managing acute lower GI bleeding
 05 May 2016 
Chemoradiotherapy vs chemotherapy for pancreatic cancer
 05 May 2016 
Reductions in quality of screening colonoscopies
 05 May 2016 
Genetics in early-early-onset IBD
 04 May 2016 
Anti-TNF therapy for IBD
 04 May 2016 
Bismuth and H. pylori eradication
 04 May 2016 
Chromoendoscopy vs colonoscopy for dysplasia in colitis
 03 May 2016 
Vedolizumab for IBD
 03 May 2016 
PPIs and gut microbiota
 03 May 2016 
Surgery vs medical therapy for GERD
 02 May 2016 
Mycophenolate mofetil as first-line treatment of autoimmune hepatitis
 02 May 2016 
Genetic variant that increase NAFLD risk
 02 May 2016 
Resection of colorectal polyps
 29 April 2016 
Simvastatins and survival in cirrhosis
 29 April 2016 
HCV infection in Baby Boomers with Medicare
 29 April 2016 
Crohn's disease associated genes
 28 April 2016 
Diarrheal diseases in children
 28 April 2016 
Birth outcomes in women with IBD receiving assisted reproduction
 28 April 2016 
Racial disparities in survival from colon cancer

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us